Joseph Preston, MD
Neurological Surgery · Paris, TXNPI 1801807649
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,000 of the $8,692 with a category attached, or 69.0%. Nvision Biomedical Technologies, Inc. accounts for 76.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $4,515 and has fallen 60.5% since, to $1,781 in 2025.
Across 27 payments — averaging $321.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nvision Biomedical Technologies, Inc.$7K
- Stryker$2K
- Spinal Elements, Inc.$170
- Johnson & Johnson$125
- Medtronic$87
- Solventum Corporation$18
What the payments were for
- Consulting fees$6,00069%
- Travel & lodging$1,91722%
- Food & beverage$7759%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nvision Biomedical Technologies, Inc. | 7 | $6,616 |
| Stryker | 11 | $1,676 |
| Spinal Elements, Inc. | 1 | $170 |
| Johnson & Johnson | 1 | $125 |
| Medtronic(2 entities) | 6 | $87 |
| Solventum Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spine products$4,500
- MAKO$1,337
- QUANTUM$1,080
- Medical Device$170
- N/A$136
- XARELTO$125
How this compares
$8,692 in reported general payments places this provider in the 65th percentile of 582 neurological surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 85 | $877 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $64 |
| Tramadol Hcl | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Paris
- Koijan KainthThe Woodlands$1.3M
- Luis DuarteSan Angelo$1.2M
- Douglas FoxAustin$948K
- Richard MeyratDallas$883K
- Adam LewisCorpus Christi$792K
- Arnold VardimanSan Antonio$687K
- Andrew RoeserHouston$660K
- Scott RobertsonRound Rock$606K
- Sabatino BiancoArlington$564K
- Rebecca StachniakPlano$561K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.